Advisors Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$535K Buy
4,544
+293
+7% +$40.9K 0.01% 954
2025
Q4
$697K Sell
4,251
-4,359
-51% -$683K 0.01% 880
2025
Q3
$1.15M Sell
8,610
-216
-2% -$26.2K 0.02% 743
2025
Q2
$1.1M Sell
8,826
-2,312
-21% -$294K 0.02% 748
2025
Q1
$1.42M Buy
11,138
+378
+4% +$58.2K 0.03% 658
2024
Q4
$1.55M Buy
10,760
+1,669
+18% +$239K 0.03% 614
2024
Q3
$1.35M Sell
9,091
-102
-1% -$14.6K 0.02% 663
2024
Q2
$1.16M Sell
9,193
-4,634
-34% -$726K 0.02% 684
2024
Q1
$2.54M Buy
13,827
+2,456
+22% +$468K 0.05% 474
2023
Q4
$2.04M Sell
11,371
-1,179
-9% -$184K 0.04% 525
2023
Q3
$2M Buy
12,550
+328
+3% +$53.6K 0.04% 506
2023
Q2
$1.73M Sell
12,222
-2,952
-19% -$473K 0.04% 563
2023
Q1
$2.55M Sell
15,174
-821
-5% -$146K 0.05% 444
2022
Q4
$2.71M Sell
15,995
-4,249
-21% -$771K 0.06% 410
2022
Q3
$3.79M Sell
20,244
-275
-1% -$58K 0.08% 289
2022
Q2
$3.33M Sell
20,519
-2,107
-9% -$333K 0.06% 337
2022
Q1
$4.26M Sell
22,626
-1,966
-8% -$373K 0.07% 320
2021
Q4
$6.51M Sell
24,592
-968
-4% -$261K 0.09% 222
2021
Q3
$7.39M Sell
25,560
-2,679
-9% -$687K 0.11% 185
2021
Q2
$5.64M Sell
28,239
-57
-0.2% -$11.1K 0.08% 233
2021
Q1
$5.5M Buy
28,296
+2,832
+11% +$581K 0.09% 229
2020
Q4
$4.88M Buy
25,464
+2,821
+12% +$513K 0.08% 244
2020
Q3
$3.34M Buy
22,643
+3,853
+21% +$551K 0.06% 298
2020
Q2
$2.32M Buy
18,790
+4,293
+30% +$505K 0.05% 406
2020
Q1
$1.4M Buy
14,497
+3,723
+35% +$359K 0.03% 520
2019
Q4
$997K Buy
10,774
+3,206
+42% +$269K 0.02% 762
2019
Q3
$580K Buy
7,568
+5,513
+268% +$482K 0.01% 934
2019
Q2
$177K Buy
2,055
+2,029
+7,804% +$138K ﹤0.01% 1210
2019
Q1
$2K Hold
26
﹤0.01% 1796
2018
Q4
$1K Hold
26
﹤0.01% 1588
2018
Q3
$1K Hold
26
﹤0.01% 1568
2018
Q2
$1K Hold
26
﹤0.01% 1575
2018
Q1
$1K Hold
26
﹤0.01% 1528
2017
Q4
$1K Hold
26
﹤0.01% 1500
2017
Q3
$1K Hold
26
﹤0.01% 1501
2017
Q2
$1K Hold
26
﹤0.01% 1556
2017
Q1
$1K Hold
26
﹤0.01% 1542
2016
Q4
$1K Hold
26
﹤0.01% 1842
2016
Q3
$1K Hold
26
﹤0.01% 1833
2016
Q2
$1K Hold
26
﹤0.01% 1851
2016
Q1
$1K Hold
26
﹤0.01% 1790
2015
Q4
$1K Sell
26
-3,400
-99% -$98.1K ﹤0.01% 1892
2015
Q3
$95K Sell
3,426
-4,158
-55% -$150K ﹤0.01% 1539
2015
Q2
$313K Sell
7,584
-513
-6% -$18.8K ﹤0.01% 1260
2015
Q1
$246K Sell
8,097
-507
-6% -$13.2K ﹤0.01% 1289
2014
Q4
$170K Buy
8,604
+1,392
+19% +$31.1K ﹤0.01% 1350
2014
Q3
$144K Buy
7,212
+3,827
+113% +$80.5K ﹤0.01% 1354
2014
Q2
$77K Buy
+3,385
New +$60.3K ﹤0.01% 1555

Other funds holding RGEN

Advisors Asset Management's RGEN Position: Q1 2026 in Review

Advisors Asset Management increased its Repligen (RGEN) stake by 6.9% in Q1 2026, buying an estimated $40.9K and bringing the position to 4,544 shares worth $535K. The position accounts for 0.01% of the portfolio, ranked #954.

Advisors Asset Management first reported a position in RGEN in Q2 2014 and has held it in 48 quarters since. The position peaked at $7.39M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Advisors Asset Management held 4,544 shares of Repligen worth $535K as of Q1 2026.
  • Advisors Asset Management bought 293 Repligen shares in Q1 2026, an estimated $40.9K.
  • Repligen made up 0.01% of Advisors Asset Management's portfolio in Q1 2026, its #954 holding.
  • Advisors Asset Management first reported a position in Repligen in Q2 2014 and has held it in 48 quarters since.
  • Advisors Asset Management's Repligen position peaked at $7.39M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.